ILSUNG IS CO., LTD. Logo

ILSUNG IS CO., LTD.

Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.

003120 | KO

Overview

Corporate Details

ISIN(s):
KR7003120003
LEI:
Country:
South Korea
Address:
서울특별시 용산구 원효로84길 9, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Based on available data, ILSUNG IS CO., LTD. is a pharmaceutical company. The firm's core focus is on antibiotics, cardiovascular drugs, anesthetics, and contrast media. It is actively expanding its therapeutic areas to include gastrointestinal (GI), central nervous system (CNS), and other related fields. The company's activities involve managing drug pipelines, conducting clinical trials, and developing patented technologies in the nervous system disease domain. Note: No information was found to support the premise of the company being a financial data provider; all relevant search results indicate a pharmaceutical business.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.2 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 922.9 KB
2025-07-22 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 44.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 833.6 KB
2025-04-28 00:00
Board/Management Information
대표이사(대표집행임원)변경(안내공시)
Korean 6.4 KB
2025-04-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.2 MB
2025-03-21 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 29.3 KB
2025-03-21 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 11.3 KB
2025-03-13 00:00
Annual Report
[첨부추가]사업보고서 (2024.12)
Korean 1.2 MB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 81.8 KB
2025-02-20 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.3 KB
2025-02-20 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 16.2 KB
2025-02-20 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 9.4 KB
2025-02-05 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 11.5 KB

Automate Your Workflow. Get a real-time feed of all ILSUNG IS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ILSUNG IS CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ILSUNG IS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.